AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
2.830
-0.090 (-3.08%)
Aug 1, 2025, 4:00 PM - Market closed
Chimerix Market Cap
AIM ImmunoTech has a market cap or net worth of $2.13 million as of August 1, 2025. Its market cap has decreased by -90.77% in one year.
Market Cap
2.13M
Enterprise Value
2.41M
1-Year Change
-90.77%
Ranking
n/a
Category
Stock Price
$2.83
Market Cap Chart
Since January 29, 2018, AIM ImmunoTech's market cap has decreased from $17.94M to $2.13M, a decrease of -88.12%. That is a compound annual growth rate of -24.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.13M | -83.45% |
| Dec 31, 2024 | 12.88M | -39.50% |
| Dec 29, 2023 | 21.29M | -52.81% |
| Dec 28, 2021 | 45.12M | -51.57% |
| Dec 21, 2020 | 93.17M | 419.24% |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.18B |
| Johnson & Johnson | 399.86B |
| AbbVie | 344.80B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| UnitedHealth Group | 222.70B |
| Abbott Laboratories | 220.45B |
| Novo Nordisk | 213.92B |